文献速递糖尿病

人胰岛单细胞RNA测序的经验教训

Lessons from single-cell RNA sequencing of human islets.
PubMed 文献 · Diabetologia · 2022-04-28

本文综述单细胞RNA测序(scRNAseq)在解析人胰岛各细胞类型转录组及2型糖尿病机制中的应用。该技术已带来细胞类型特异性基因表达调控的重要观察,但用于识别2型糖尿病疾病机制时结果仍有限,多项研究鉴定的差异表达基因间共识非常有限。文章总结scRNAseq对胰岛生物学的贡献,聚焦剩余挑战并提出促进其潜力发挥的步骤。

要点

  • scRNAseq已实现对胰岛各细胞类型转录组的表征并带来基因表达调控的重要观察。
  • 用于识别2型糖尿病疾病机制时结果仍有限,各研究鉴定的差异表达基因间共识非常有限。
  • scRNAseq存在费用极高、低表达基因可能检测不到、噪音可能未被适当过滤及细胞类型选择偏倚等局限。

核心结论

  • scRNAseq为表征胰岛各细胞类型转录组带来突破,但用于识别2型糖尿病疾病机制的结果仍有限。

研究设计与样本

  • 综述,总结scRNAseq对人胰岛生物学及2型糖尿病疾病机制研究的贡献,并讨论剩余挑战与促进其潜力发挥的步骤。

主要发现

  • 多项研究鉴定了差异表达基因,但研究间共识非常有限。
  • scRNAseq已就细胞类型特异性基因表达调控作出若干重要观察。
  • 近期进展提示常用计算工具在小规模研究的scRNAseq数据分析中可能非最优。

局限性

  • scRNAseq极其昂贵。
  • 低表达水平的基因可能检测不到。
  • 噪音可能未被适当过滤。
  • 存在针对某些细胞类型的选择偏倚。
  • 近期进展提示常用计算工具在小规模研究的scRNAseq数据分析中可能非最优。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Islet dysfunction is central in type 2 diabetes and full-blown type 2 diabetes develops first when the beta cells lose their ability to secrete adequate amounts of insulin in response to raised plasma glucose. Several mechanisms behind beta cell dysfunction have been put forward but many important questions still remain. Furthermore, our understanding of the contribution of each islet cell type in type 2 diabetes pathophysiology has been limited by technical boundaries. Closing this knowledge gap will lead to a leap forward in our understanding of the islet as an organ and potentially lead to improved treatments. The development of single-cell RNA sequencing (scRNAseq) has led to a breakthrough for characterising the transcriptome of each islet cell type and several important observations on the regulation of cell-type-specific gene expression have been made. When it comes to identifying type 2 diabetes disease mechanisms, the outcome is still limited. Several studies have identified differentially expressed genes, although there is very limited consensus between the studies. As with all new techniques, scRNAseq has limitations; in addition to being extremely expensive, genes expressed at low levels may not be detected, noise may not be appropriately filtered and selection biases for certain cell types are at hand. Furthermore, recent advances suggest that commonly used computational tools may be suboptimal for analysis of scRNAseq data in small-scale studies. Fortunately, development of new computational tools holds promise for harnessing the full potential of scRNAseq data. Here we summarise how scRNAseq has contributed to increasing the understanding of various aspects of islet biology as well as type 2 diabetes disease mechanisms. We also focus on challenges that remain and propose steps to promote the utilisation of the full potential of scRNAseq in this area.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ngara M, Wierup N. Lessons from single-cell RNA sequencing of human islets. Diabetologia. 2022. PMID: 35482056. doi:10.1007/s00125-022-05699-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。